|1.||Kesler-Roussey, G: 1 article (10/2015)|
|2.||Tiulpakov, A: 1 article (10/2015)|
|3.||Kottler, M-L: 1 article (10/2015)|
|4.||Deschenes, G: 1 article (10/2015)|
|5.||Kaufmann, M: 1 article (10/2015)|
|6.||Ryckewaert, A: 1 article (10/2015)|
|7.||Bacchetta, J: 1 article (10/2015)|
|8.||Vantyghem, M C: 1 article (10/2015)|
|9.||Coudray, N: 1 article (10/2015)|
|10.||Richard, N: 1 article (10/2015)|
03/01/1983 - "Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia."
01/01/1989 - "At the doses prescribed, the results of treatment of dialysis osteomalacia with 24R,25-dihydroxycholecalciferol were clinically unsatisfactory."
01/01/1989 - "Persistence of dialysis osteomalacia despite treatment with 24R,25-dihydroxycholecalciferol."
03/01/1983 - "Fifteen patients with dialysis osteomalacia were treated with 24,25-dihydroxyvitamin D3 in dosages up to 10 micrograms per day for two to 24 months. "
01/01/1989 - "Five patients with symptomatic osteomalacia undergoing chronic hemodialysis took 24R,25-dihydroxycholecalciferol, 10 micrograms/day, for periods of 6-20 months. "
|2.||Chronic Kidney Failure (Chronic Renal Failure)
07/01/1990 - "[The effect of 24,25-dihydroxyvitamin D3 (dioxyvit) on Ca metabolism and immune status during chronic kidney failure]."
09/01/1981 - "A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure."
01/01/1992 - "Twelve patients with chronic renal failure (CRF) requiring dialysis, 7 of whom were hypercalcaemic, were treated with 24,25-dihydroxycholecalciferol [24,25(OH)2D3; 10 micrograms daily for 3 months] or placebo and the treatment then crossed over for a further 3 months. "
05/01/2000 - "24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure."
01/01/1999 - "The concentrations of (24R)-24,25-dihydroxyvitamin D3[24,25(OH)2D3], 25-hydroxyvitamin D3[25(OH)D3] and its 3-sulphate [25(OH)D3(3)S] in the plasma of healthy subjects, patients with chronic renal failure, patients with climacteric syndrome, pregnant women and foetuses were determined using the enzyme-linked immunosorbent assay and high-performance liquid chromatography. "
05/01/1983 - "Administration of 24,25-dihydroxycholecalciferol, an active metabolite of vitamin D3, at a dose of 1.25 micrograms/d prevented a development of bone disorders, thus effectively stimulating diaphyses and epiphyses mineralization and correcting hypocalcemia in hypokinetic rats. "
09/01/1982 - "24,25-Dihydroxycholecalciferol, an active D3 vitamin metabolite, at a dose of 1.25 microgram/day/animal prevents bone osteoporotic changes, effectively stimulating the diaphyseal and epiphyseal mineralization, and corrects hypocalcemia of hypokinetic rats. "
01/01/1984 - "Pigs fed vitamin D-deficient diet had a 5- to 10-fold increase in 1 alpha-hydroxylase activity, severe hypocalcemia, low plasma, 1,25-dihydroxycholecalciferol, very low plasma (undetectable) 24,25-dihydroxycholecalciferol concentration, and no detectable 24-hydroxylase activity compared to those fed the vitamin D-replete diet."
02/01/1984 - "Vitamin D replete normal mice and Hyp littermates fed the control diet synthesized primarily 24,25-dihydroxyvitamin D3 (24,25-(OH)2D3); only minimal synthesis of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) was detected in both genotypes and 1,25-(OH)2D3 formation was not significantly greater in Hyp mice relative to normal littermates, despite hypophosphatemia and hypocalcemia in the mutants. "
12/01/1982 - "Five patients with involutional osteoporosis were treated with 24,25 dihydroxycholecalciferol (24,25-(OH)2D3) for 6 months, in doses sufficient to double plasma levels at that time. "
12/01/1982 - "Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol."
05/01/1989 - "On histology, normal findings and non-age related osteoporosis on histology were associated with low serum levels of 25-hydroxyvitamin D3, 1,25- and 24,25-dihydroxyvitamin D3. "
05/01/1989 - "Calcitonin improved calcium balance, reduced osteoporosis and increased the serum 1,25- and 24,25-dihydroxyvitamin D3 levels but had no effect on osteomalacia. "
01/01/2005 - "Comparative study results of vitamin's D active metabolites 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 24,25-dihydroxycholecalciferol (24,25(OH)2D3) effect on ionised calcium level in blood plasma of patients with postmenopause osteoporosis are described. "
|5.||Renal Insufficiency (Renal Failure)
01/01/1980 - "The effects of 24,25-dihydroxyvitamin D3 (24,25[OH]2D3), given orally for 7-10 days at doses of 2 and 4 microgram/day, were evaluated in patients with advanced renal failure. "
06/01/1983 - "The available data with regard to the use of calcitriol, 1 alpha-hydroxyvitamin D3 (1 alpha-OH D3), and 24,25-dihydroxyvitamin D3 (24,25-[OH]2D3) in the management of chronic renal insufficiency are reviewed. "
|6.||Calcitonin (Calcitonin, Eel)
|9.||Tretinoin (Retinoic Acid)
|3.||Renal Dialysis (Hemodialysis)